Printer Friendly

Iowa Congressman declared his Lyme disease cured by bovine colostrum and helped create the law guaranteeing availability of natural remedies (DSHEA).

Not many dietary supplements can claim that they were instrumental in the passage of the Dietary Supplement Health and Education Act (DSHEA). Yet, that's precisely what happened.

Former Iowa Congressman Berkley Bedell (D-Iowa) suffered from Lyme disease and did not recover with multiple, long-term antibiotic use. Due to severe debilitation, Congressman Bedell eventually had to retire from Congress, but first, he paved the way to DSHEA. On the way to personal healing, Congressman Bedell discovered a farmer who was using cows to develop specific ("hyperimmunized") colostrum for specific diseases. Fortunately, the congressman experienced a full recovery from Lyme disease. Unfortunately, the farmer was arrested for practicing medicine without a license.

It didn't seem right that an individual could be punished for supplying a safe, all-natural substance which promotes healing simply because it was overlooked by mainstream medicine, so Congressman Bedell joined forces with like-minded senators and in 1994, the Dietary Supplement Health and Education Act was signed into law by President Clinton. DSHEA was very important to the development of bovine colostrum as a health-enhancing supplement.

In the last 20 years, colostrum manufacturing for human consumption has undergone a tremendous transformation. We now know that hyperimmunization of cows is not a requirement for colostrum's broad spectrum capabilities and that fresh, raw colostrum can be made into supplements with an extended shelf-life. Better processing methods also allow for colostrum to contain a higher percentage of bioactives. Colostrum-LD[R] has been perfected to be effective against thousands of infections, something not possible in Congressman Bedell's day. Colostrum-LD[R]'s unique broad spectrum profile sets it apart from ordinary colostrum, and treating bacterial infections with ColostrumLD[R] can be effective where antibiotics have failed.

Colostrum-LD[R] does not contain specific antibodies for Lyme. It doesn't need to. It helps the immune system successfully fight the pathogens within the body. Among the more than 280 bioactives known to affect the immune system by killing pathogens or modulating T-cell and macrophage production, the Proline-Rich Polypeptides (PRPs) are the most significant. In fact, PRPs can increase natural killer cell activity by up to forty times. Lyme disease is just one of thousands of bacterial and viral infections that Colostrum-LD[R] can effectively treat, including HIV, E-coli, C-difficile, Rotavirus and Cryptosporidium.

A major downside to conventional Lyme disease treatment with antibiotics is that it actually worsens a patient's prognosis. Antibiotics are never 100% effective; they leave resistant bacteria behind; and when taken for extended periods of time, cause destruction of the gut lining and increased gut permeability, or Leaky Gut Syndrome (LGS) which in turn, contributes to autoimmune conditions. Acknowledging the causal effect of antibiotics on LGS will help practitioners more fully understand why colostrum is so critical to a successful treatment program. Douglas Wyatt (Founder and Medical Director of the Center for Nutritional Research) recommends Colostrum-LD[R], the only colostrum laboratory-certified to contain all of the growth factors clinically proven to heal LGS. Put your patients on the path to recovery, even after years of antibiotics have already taken their toll. If you have a patient with Lyme disease who is not recovering and may have subsequently developed another autoimmune condition, Mr. Wyatt is available for consultation. To learn more about the bioactives in Colostrum-LD[R] responsible for immune health, please visit www.Colostrum
COPYRIGHT 2015 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Berkley Bedell
Publication:Townsend Letter
Date:Jul 1, 2015
Previous Article:Multifactorial approaches to Lyme infection.
Next Article:Lyme disease and detection in 2015.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters